Biotech ETF Rises 17% in a Month Without NVIDIA
A biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
Explore common reasons budgets fail and practical fixes you can apply now to improve accuracy, discipline, and long-term results.
20,131 articlesA biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
Mastercard plans to buy London-based BVNK for up to $1.8 billion, creating the largest stablecoin deal to date and ac...
A federal judge revived a fraud claim in the Genesis Yield class action against Barry Silbert and Digital Currency Gr...
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Greg Abel, the man tapped to carry on Warren Buffett's investing legacy, is making a bold AI move with Alphabet. Berk...
A seasoned investor at Benchmark warns that the AI boom may be inflating prices beyond fundamentals, signaling a comi...
A three-week ban on Anthropic's AI services by U.S. regulators ended, igniting a debate over whether the episode coul...
Chord Energy reports strong 2025 results driven by Williston Basin efficiency, but investors question whether this wi...
SoFi Technologies beat first-quarter expectations on revenue and loan originations, staving off a short-seller attack...
A newer NEOS-led family of covered call ETFs is drawing attention for stronger NAV resilience and higher income poten...
Bank of America stock just surged to a record high as investors await quarterly results. This guide breaks down what ...
What could propel Ripple's XRP toward a trillion-dollar valuation in the next decade? This comprehensive guide breaks...